Lorenz P, Pepperkok R, Ansorge W, Pyerin W
Biochemical Cell Physiology, German Cancer Research Center, Heidelberg.
J Biol Chem. 1993 Feb 5;268(4):2733-9.
Casein kinase II (CKII) is a highly conserved ubiquitous serine/threonine kinase composed of two catalytically active (alpha and/or alpha') and two regulatory (beta) subunits. It has been suspected that, among numerous other cellular functions, CKII might play a role in the control of mitogenic signaling. To test for such a role and its mechanism in intact cells, monoclonal antibodies (mAbs) were generated against CKII beta using a recombinant protein containing amino acids 20-200 of human CKII beta. The CKII beta-specific mAb with the highest reactivity, mAb IVG6 (classified as IgG1 with kappa light chains), was purified to homogeneity. It recognized a CKII beta epitope comprising the amino acids 140-156, a basic and highly conserved region. In addition, polyclonal antibodies (pAbs) were raised and made monospecific by affinity purification. pAbs-mediated quantitative immunofluorescence microscopy of human IMR-90 fibroblasts and/or Western blots of cell fractions revealed (i) CKII beta was present in exponentially growing cells at a 2-3-fold higher level than in quiescent cells, (ii) CKII beta was localized predominantly in the nucleus of cells (3-15-fold cytoplasmic level depending on cellular state and assay used), and (iii) the nuclear/cytoplasmic ratio of CKII beta was higher by a factor of 2 in exponentially growing cells. Consequently, mitogenic stimulation of quiescent cells by fetal calf serum doubled the nuclear/cytoplasmic ratio of CKII beta. The increase occurred within the 1st h of stimulation. The translocation of CKII beta into the nucleus was inhibited when mAb IVG6 was injected into the cytoplasm at the time of mitogenic stimulation. This microinjection also significantly inhibited the cell proliferation. The data imply that cytoplasmic CKII participates in the transmission of mitogenic signals by translocation into the nucleus.
酪蛋白激酶II(CKII)是一种高度保守的普遍存在的丝氨酸/苏氨酸激酶,由两个具有催化活性的亚基(α和/或α')和两个调节亚基(β)组成。人们怀疑,在众多其他细胞功能中,CKII可能在有丝分裂信号的控制中发挥作用。为了测试其在完整细胞中的这种作用及其机制,使用包含人CKIIβ氨基酸20 - 200的重组蛋白产生了针对CKIIβ的单克隆抗体(mAb)。反应性最高的CKIIβ特异性单克隆抗体mAb IVG6(归类为具有κ轻链的IgG1)被纯化至同质。它识别一个包含氨基酸140 - 156的CKIIβ表位,这是一个碱性且高度保守的区域。此外,制备了多克隆抗体(pAb)并通过亲和纯化使其具有单特异性。pAb介导的对人IMR - 90成纤维细胞的定量免疫荧光显微镜检查和/或细胞组分的蛋白质印迹分析表明:(i)处于指数生长期的细胞中CKIIβ的水平比静止细胞高2 - 3倍;(ii)CKIIβ主要定位于细胞核中(根据细胞状态和所用检测方法,其在细胞质中的水平为细胞核中的3 - 15倍);(iii)在指数生长期的细胞中,CKIIβ的核/质比高2倍。因此,胎牛血清对静止细胞的有丝分裂刺激使CKIIβ的核/质比加倍。这种增加在刺激的第1小时内发生。在有丝分裂刺激时将mAb IVG6注入细胞质中会抑制CKIIβ向细胞核的转运。这种显微注射也显著抑制了细胞增殖。这些数据表明细胞质中的CKII通过转运到细胞核中参与有丝分裂信号的传递。